-
Forward Look
Boosting Defenses Against CancerQ&A with immunologist James P. Allison, Memorial Sloan-Kettering Cancer Center, New York City.
by Ingfei Chen
-
Forward Look
Second-Cancer Clues?Genetic marker discovery could help childhood Hodgkin survivors assess risks associated with radiation.
by Mitzi Baker
-
Staying the CoursePatients are increasingly skipping treatment breaks and opting for ongoing treatment known as maintenance therapy to try to keep some types of cancer at bay.
by Melissa Weber
-
Forward Look
A Burning Question for SmokersIs the considerable risk-reduction benefit of CT screening worth the potential downsides?
by Sue Rochman
-
Survivor Profile
When Cancer Meets Inner DriveDiagnosed at 28, Rochelle Shoretz has stayed true to her big dreams and to her goal of helping other young women with breast cancer.
by Yvonne Lee
-
Yesterday & Today
A King’s LegacyMore than a quarter century after Yul Brynner's death from lung cancer, treatment advances offer some patients new options, but the cancer continues to claim more lives than any other. And the actor's haunting anti-smoking message lives on.
by Sue Rochman
-
The Wait for a MatchMany patients in urgent need of bone marrow or stem cell transplants are facing uncertainty.
by Karen Patterson
-
Forward Look
Avastin’s FateDebate goes on as FDA revokes drug's use for breast cancer.
by Alanna Kennedy-Gorman
-
Global Report
Stark Realities in ZambiaAn American cancer survivor's visit to a Southern African nation reveals how doctors are adapting cancer care to meet an overwhelming need.
by Cynthia Ryan
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona
Support for Cancer Today has been provided in part by an independent educational grant from Merck & Co., Inc.
All editorial content is produced independently by the Cancer Today editorial team.
-
Ultraproccessed Foods and Cancer RiskThe idea that ultraprocessed foods are associated with increased risk of metabolic and cardiovascular diseases is well supported, but what does the evidence reveal about these foods and cancer?
-
What Are the Benefits of Exercise for Cancer Patients?Several recent studies have explored how exercise can impact a cancer patient’s survival, risk of recurrence, and overall quality of life.
Cancer Research at a Crossroads
Support for Cancer Today has been provided in part by an independent educational grant from Merck & Co., Inc.
All editorial content is produced independently by the Cancer Today editorial team.
